StockWatch
·

BAL PHARMA LTD.

BSE: 524824

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-12.8925.2963.46101.64Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
-12.88-3.266.3715.99Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue88.43+5.4%83.92-4.1%87.49+18.6%73.75+12.4%65.64-19.7%81.78+12.2%72.89-2.4%74.70
Other Income0.46+309.5%-0.22-163.2%0.35-69.6%1.13+53.1%0.74-25.2%0.99+20.9%0.82+137.7%0.34
Total Income88.88+6.2%83.70-4.7%87.84+17.3%74.88+12.8%66.38-19.8%82.77+12.3%73.70-1.8%75.05
EXPENSES
Expenditure87.72+9.1%80.39-6.4%85.89+15.9%74.10+12.2%66.05-17.4%79.96+10.3%72.50-1.4%73.52
Tax0.00+100.0%-0.390.000.000.00+100.0%-2.79-5919.0%0.05-85.0%0.32
PROFIT
PBT1.16-65.0%3.31+70.3%1.95+149.0%0.78+141.7%0.32-88.5%2.81+133.7%1.20-20.9%1.52
Net Profit1.16-68.6%3.70+90.1%1.95+149.0%0.78+141.7%0.32-94.2%5.61+385.0%1.16-3.9%1.20
KEY METRICS
OPM %8.99%-3.67pp12.66%+1.60pp11.06%+3.23pp7.83%-1.54pp9.37%-0.21pp9.58%+19.13pp-9.55%-2.69pp-6.86%
NPM %1.31%-3.11pp4.42%+2.20pp2.22%+1.18pp1.04%+0.55pp0.49%-6.28pp6.77%+5.20pp1.57%-0.03pp1.60%
EPS0.73-71.9%2.60+113.1%1.22+149.0%0.49+145.0%0.20-94.3%3.51+380.8%0.73-3.9%0.76

Corporate Events

Board MeetingBALPHARMA
2026
24Sep

Board Meeting

The Board of Directors approved and fixed the date and time …

BSE Filing
DividendBALPHARMA
2026
17Sep

₹1.2 / share

BSE Filing
Board MeetingBALPHARMA
2026
12Aug

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing
Board MeetingBALPHARMA
2026
27May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing
Board MeetingBALPHARMA
2025
13Feb

Board Meeting

Regular agenda items

BSE Filing
Board MeetingBALPHARMA
2024
14Nov

Board Meeting

To take on record and approve the Un-audited standalone and …

BSE Filing
Board MeetingBALPHARMA
2024
9Sep

Board Meeting

Allotment Of Equity Shares To The Employees Of The Company U…

BSE Filing
Board MeetingBALPHARMA
2024
28May

Board Meeting

Approval of Audited Standalone and Consolidated financial re…

BSE Filing
Board MeetingBALPHARMA
2024
12Feb

Board Meeting

Approval of Un-audited Standalone and Consolidated financial…

BSE Filing
Board MeetingBALPHARMA
2023
8Nov

Board Meeting

Approval of Un-audited Standalone and Consolidated financial…

BSE Filing
DividendBALPHARMA
2023
25Sep

₹0.01 / share

BSE Filing
Board MeetingBALPHARMA
2023
11Aug

Board Meeting

Consideration and approval of Un-Audited Standalone and Cons…

BSE Filing